A circulating TH2 cytokines profile predicts survival in patients with resectable pancreatic adenocarcinoma

45Citations
Citations of this article
62Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Surgery is the only potentially curative option for patients with pancreatic ductal adenocarcinoma (PDAC), but metastatic relapse remains common. We hypothesized that the expression levels of inflammatory cytokines could predict recurrence of PDAC, thus allowing to select patients who most likely could benefit from surgical resection. We prospectively collected plasma at diagnosis from 287 patients with pancreatic resectable neoplasms. The expression levels of 23 cytokines were measured in 90 patients with PDAC by using a multiplex analyte profiling assay. Levels higher than cutoff identified of the TH2 cytokines interleukin (IL)4, IL5, IL6 of macrophage inflammatory protein (MIP)1α, granulocyte-macrophage colony-stimulating factor (GM-CSF), and monocyte chemoattractant protein (MCP)1, and of IL17α, IFNγ-induced protein (IP)10, and IL1b were significantly associated with a shorter median OS. In particular, levels of IL4 and IP10 higher than cutoff identified, and level of TH1 cytokines TNFα and INFγ, and of IL9 and IL1Rα lower than cutoff identified were significantly associated with a shorter DFS. In the multivariate analysis, high IP10 was confirmed as negatively associated with OS (HR = 3.097, p = 0.014) and IL4 and TNFα remain negatively (HR = 2.75, p = 0.002) and positively (HR = 0.224, p = 0.049) associated with DFS, respectively. Simultaneous expression of low IL4 and high TNFα identified patients with best prognosis (HR = 0.313, p < 0.0001). In conclusion, we demonstrated that, among a series of cytokines, IL4 is the most significant independent prognostic factor for DFS in resectable PDAC patients, and it could be useful to select patients with high risk of early recurrence who may avoid an unnecessary resection.

References Powered by Scopus

Cancer statistics, 2015

12203Citations
N/AReaders
Get full text

Index for rating diagnostic tests

9004Citations
N/AReaders
Get full text

Immunity, Inflammation, and Cancer

8827Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Galunisertib plus gemcitabine vs. gemcitabine for first-line treatment of patients with unresectable pancreatic cancer

218Citations
N/AReaders
Get full text

Fungal mycobiome drives IL-33 secretion and type 2 immunity in pancreatic cancer

194Citations
N/AReaders
Get full text

Chemokines and their receptors: Multifaceted roles in cancer progression and potential value as cancer prognostic markers

167Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Piro, G., Simionato, F., Carbone, C., Frizziero, M., Malleo, G., Zanini, S., … Melisi, D. (2017). A circulating TH2 cytokines profile predicts survival in patients with resectable pancreatic adenocarcinoma. OncoImmunology, 6(9). https://doi.org/10.1080/2162402X.2017.1322242

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 20

65%

Researcher 9

29%

Professor / Associate Prof. 1

3%

Lecturer / Post doc 1

3%

Readers' Discipline

Tooltip

Medicine and Dentistry 17

44%

Biochemistry, Genetics and Molecular Bi... 12

31%

Immunology and Microbiology 6

15%

Agricultural and Biological Sciences 4

10%

Save time finding and organizing research with Mendeley

Sign up for free